ReviewExperimental hematology & oncology2023

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma.

Tingxun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.